UCSF Adult Inpatient Susceptibility Data (Gram-Positives)1
R-testing not applicable to organism and should be considered resistant, AMP-ampicillin, CLIN-clindamycin, CTRX-ceftriaxone, DAP-daptomycin, DOX-doxycycline, LZD-linezolid, NAF-nafcillin, T/S-trimethoprim/sulfamethoxazole, VANC-vancomycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
Organism |
Total Isolates |
AMP |
CLIN |
CTRX |
DAP |
DOX |
LZD |
NAF |
T/S |
VANC |
|---|---|---|---|---|---|---|---|---|---|---|
|
Staphylococcus aureus |
887 |
R |
74 |
R |
100 |
88 |
100 |
76 |
96 |
100 |
|
MSSA |
690 |
R |
78 |
R |
100 |
92 |
100 |
99 |
97 |
100 |
|
MRSA |
207 |
R |
60 |
R |
100 |
76 |
100 |
R |
94 |
100 |
|
Staphylococcus epidermidis |
108 |
R |
55 |
R |
100 |
75 |
100 |
40 |
51 |
100 |
|
Enterococcus faecalis (bloodstream isolates only)2 |
92 |
100 |
R |
R |
95 |
27 |
100 |
R |
R |
100 |
|
Enterococcus faecium (bloodstream isolates only)2 |
94 |
12 |
R |
R |
993 |
36 |
96 |
R |
R |
40 |
1Adult inpatient susceptibilities include data from 4/1/22-3/31/23; 2Isolates pooled from 4/1/20-3/31/23 given low number of yearly isolates; 3Represents susceptible dose-dependent isolates